Nurse Practitioner, Family · Newburgh, IN
NPI
1609363852
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
5
Medicare group memberships
Hospitals
1
Hospital affiliations
100 St Mary's Epworth Crossing Suite B100
Newburgh, IN, 47630
Phone (812) 853-9651
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
308 services
Medicare patients, 2024
61
Average age 71
Drug cost, 2024
$331K
1,934 prescriptions
Company payments, 2025
$566
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Megan A Seifert was code 99214 (office e&m - established), 79 times for 23 patients. In total Megan A Seifert billed 308 services in 26 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 79 | 23 | $74.09 | $5,853 |
| 99309 SNF E&M | Office | 60 | 30 | $50.60 | $3,036 |
| 87804 Immunoassay | Office | 30 | 13 | $16.22 | $487 |
| 87811 Immunoassay | Office | 15 | 13 | $40.55 | $608 |
By year: 2022 $29K for 1,292 services; 2023 $22K for 422 services; 2024 $16K for 308 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87804 Immunoassay | 30 | 13 | $16.22 | $487 |
| 87811 Immunoassay | 15 | 13 | $40.55 | $608 |
Medicare prescription drug claims, 2024
In 2024, the drug Megan A Seifert prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 118 prescriptions and refills. In total Megan A Seifert wrote 1,934 Medicare prescriptions that cost $331K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 118 | 118 | 27 | $2,040 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 114 | 114 | 24 | $16K |
| Ondansetron Hcl Generic | 96 | 264 | 50 | $232K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 78 | 87 | 30 | $439 |
| Gabapentin Generic | 75 | 89 | 18 | $811 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 67 | 67 | 13 | $1,323 |
| Atorvastatin Calcium Generic | 50 | 147 | 22 | $166 |
| Aripiprazole Generic | 38 | 108 | 17 | $7,291 |
| Prednisone Generic | 37 | 39 | 27 | $54.79 |
| Rosuvastatin Calcium Generic | 36 | 108 | 17 | $130 |
| Amlodipine Besylate-Benazepril Amlodipine Besylate/Benazepril | 32 | 96 | 14 | $190 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 31 | 79 | 15 | $4,898 |
| Celecoxib Generic | 30 | 68 | 14 | $2,634 |
| Doxycycline Hyclate Generic | 29 | 29 | 19 | $177 |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 28 | 82 | 14 | $5,809 |
Brand drugs: - claims; generic drugs: 1,781 claims; opioid claims: 214.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Megan A Seifert $566 ($566 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $181.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 13 | $181 |
| Axsome Therapeutics, Inc. AXSM | 8 | $87.62 |
| Vanda Pharmaceuticals Inc. VNDA | 4 | $87.55 |
| Indivior Inc. INDV | 2 | $44.11 |
| Tris Pharma Inc | 2 | $33.73 |
| Alkermes, Inc. ALKS | 2 | $29.97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $29.11 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $24.6 |
| GlaxoSmithKline, LLC. GSK | 1 | $18.05 |
| Pfizer Inc. PFE | 1 | $16.28 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.